| Literature DB >> 29778233 |
Claudio Luchini1, Alessia Nottegar2, Alberto Vaona3, Brendon Stubbs4, Jacopo Demurtas5, Stefania Maggi6, Nicola Veronese7.
Abstract
Recent studies highlighted the role of mitochondrial dysregulation in cancer, suggesting that the different mitochondrial haplogroups might play a role in tumorigenesis and risk of cancer development. Our aim is to investigate whether any mitochondrial haplogroups carried a significant higher risk of cancer development in a large prospective cohort of North American people. The haplogroup assignment was performed by a combination of sequencing and PCR-RFLP techniques. Our specific outcome of interest was the incidence of any cancer during follow-up period. Overall, 3222 participants were included in the analysis. Women having I, J, K haplogroup reported a significant higher incidence of cancer compared to people with other haplogroups (p < 0.0001), whilst in men non association was found. In the multivariate analysis, women having I, J, K mitochondrial haplogroup reported a 50% increased risk of cancer (HR = 1.50; 95%CI: 1.04-2.16; p = 0.03). This gender-linked association may be partly explained by the role of mitochondrial function in female-specific (e.g. BRCA-driven) oncogenesis, but further studies are needed to better understand this potential correlation. Our findings may have important implications for cancer epidemiology and prevention.Entities:
Keywords: Cancer; Haplogroup; Mitochondrial; Oncogenesis; Screening
Mesh:
Substances:
Year: 2018 PMID: 29778233 PMCID: PMC5973548 DOI: 10.1016/j.cancergen.2018.04.003
Source DB: PubMed Journal: Cancer Genet